Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Real-world post-marketing surveillance study of injectable teicoplanin
ChiCTR-OPN-17010364Phase 4Recruiting
- Sponsor
- Peking Union Medical College Hospital
- Start
- Jan 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of teicoplanin in Infectious disease, sponsored by Peking Union Medical College Hospital. Primary endpoint: Clinical efficacy. Started Jan 2017; status: recruiting.
02
Drugs
teicoplanin
03
Conditions
Infectious disease
Beyond the preview
Go deeper on ChiCTR-OPN-17010364.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-OPN-17010364.